A novel testing platform under development by researchers at the Yale School of Public Health (YSPH) and CytoAstra, LLC could provide a new noninvasive test for malaria that doesn’t require a blood sample.
FDA approves Duchenne gene therapy with hefty $3.2m price tag – Pharmaceutical Technology
The approval comes after an intermittent regulatory home stretch for Sarepta’s Duchenne therapy. Image credit: Shutterstock/T. Schneider. Children with a confirmed mutation of the DMD
June 23, 2023